Development

Feliza Mirasol is the science editor for 

Videos

Karunakar Sukuru, RPh, PhD, the global vice-president-Rx Product Development, Pharma and Consumer Health, at Catalent Pharma Solutions, discussed lipid-based formulations and tackling bioavailability challenges for oral biologics at AAPS PharmSci 360.

The Need for LBFs and Challenges in Oral Biologic Formulation (AAPS PharmSci 360)

Podcasts

This podcast explores the challenges of and the progress made so far by the biopharma industry toward alternative drug delivering methods for biologic drugs.

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Articles

Alternative delivery methods for biologics continues to be explored that offer less invasive, less painful administration.

Exploring Innovative Means for Biologics Delivery

AAV and lentivirus both have pros and cons in their use for specific gene therapy applications.

Comparing Viral Vectors for Gene Therapy Delivery

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

Roche voluntarily recalled Susvimo’s ocular implant, insertion tool, and initial fill kit when test results did not satisfy company standards.

nAMD Treatment Reintroduced by Roche in US Following FDA Updates

Swiss CDMO CordenPharma and Spain-based Certest will collaborate on the development of ionizable lipids for LNP formulations.

CordenPharma Partners with Certest to Develop Ionizable Lipids for LNP Formulations

Tao Peng, PhD, is biopharma research manager at Roquette.

A comparison between polysorbates and HPβCD determines the better stabilizer for biologics formulation.

Polysorbates: Part(icle) of the Problem?

Pemba Lahmo is associate principal at Roots Analysis.

This article represents a comprehensive exploration about biopharmaceutical excipients, exploring their multifaceted classification, active role in drug formulation processes, inherent challenges, and upcoming advancements poised to revolutionize the drug formulation and its efficacy for patient welfare.

Biopharmaceutical Excipients: Everything You Need to Know

Editor of Pharmaceutical Technology Europe

Despite slow growth over recent years, the CAR-T cell therapy space is expected to see considerable advancements in the near future.

Developing CAR-T Cell Therapies for the Future

Part of the session "Transforming Medicine: Unleashing the Potential of Cell and Gene Therapies," Sadelain discusses CAR-T cells for immunotherapy and the future of cell/gene therapies.

Formulation and Drug Delivery, Biologic Drugs